Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Small

Showing results (111-120 of 131) with videos related to

Pageof 14
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 30, 2008
Response to pneumococcal (PNCRM7) and haemophilus influenzae conjugate vaccines (HIB) in pediatric and adult recipients of an allogeneic hematopoietic cell transplantation (alloHCT)Mary Pao, Esperanza B Papadopoulos, Joanne Chou, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 15, 2011
T cell-depleted unrelated donor stem cell transplantation provides favorable disease-free survival for adults with hematologic malignanciesAnn A Jakubowski, Trudy N Small, Nancy A Kernan, et al.
Blood|August 25, 2007
T cell depleted stem-cell transplantation for adults with hematologic malignancies: sustained engraftment of HLA-matched related donor grafts without the use of antithymocyte globulinAnn A Jakubowski, Trudy N Small, James W Young, et al.
Bone Marrow Transplantation|July 10, 2007
Long-term follow-up of patients treated with daclizumab for steroid-refractory acute graft-vs-host diseaseM-A Perales, N Ishill, W A Lomazow, et al.
Blood|January 13, 1999
Comparison of immune reconstitution after unrelated and related T-cell-depleted bone marrow transplantation: effect of patient age and donor leukocyte infusionsT N Small, E B Papadopoulos, F Boulad, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2002
Safe and cost effective use of alteplase for the clearance of occluded central venous access devicesJ P Timoney, M G Malkin, D M Leone, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 18, 2008
Transplantation in remission improves the disease-free survival of patients with advanced myelodysplastic syndromes treated with myeloablative T cell-depleted stem cell transplants from HLA-identical siblingsHugo Castro-Malaspina, Ann A Jabubowski, Esperanza B Papadopoulos, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 24, 2007
Fludarabine-based conditioning secures engraftment of second hematopoietic stem cell allografts (HSCT) in the treatment of initial graft failureJoseph H Chewning, Hugo Castro-Malaspina, Ann Jakubowski, et al.
Leukemia & Lymphoma|January 12, 2017
Early recovery of T-cell function predicts improved survival after T-cell depleted allogeneic transplantJenna D Goldberg, Junting Zheng, Ravin Ratan, et al.
The Journal of Allergy and Clinical Immunology|December 17, 2009
Improving cellular therapy for primary immune deficiency diseases: recognition, diagnosis, and managementLinda M Griffith, Morton J Cowan, Luigi D Notarangelo, et al.
Pageof 14

Showing results (111-120 of 131) with videos related to

Sort By:
Pageof 14
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 30, 2008
Response to pneumococcal (PNCRM7) and haemophilus influenzae conjugate vaccines (HIB) in pediatric and adult recipients of an allogeneic hematopoietic cell transplantation (alloHCT)Mary Pao, Esperanza B Papadopoulos, Joanne Chou, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 15, 2011
T cell-depleted unrelated donor stem cell transplantation provides favorable disease-free survival for adults with hematologic malignanciesAnn A Jakubowski, Trudy N Small, Nancy A Kernan, et al.
Blood|August 25, 2007
T cell depleted stem-cell transplantation for adults with hematologic malignancies: sustained engraftment of HLA-matched related donor grafts without the use of antithymocyte globulinAnn A Jakubowski, Trudy N Small, James W Young, et al.
Bone Marrow Transplantation|July 10, 2007
Long-term follow-up of patients treated with daclizumab for steroid-refractory acute graft-vs-host diseaseM-A Perales, N Ishill, W A Lomazow, et al.
Blood|January 13, 1999
Comparison of immune reconstitution after unrelated and related T-cell-depleted bone marrow transplantation: effect of patient age and donor leukocyte infusionsT N Small, E B Papadopoulos, F Boulad, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2002
Safe and cost effective use of alteplase for the clearance of occluded central venous access devicesJ P Timoney, M G Malkin, D M Leone, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 18, 2008
Transplantation in remission improves the disease-free survival of patients with advanced myelodysplastic syndromes treated with myeloablative T cell-depleted stem cell transplants from HLA-identical siblingsHugo Castro-Malaspina, Ann A Jabubowski, Esperanza B Papadopoulos, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 24, 2007
Fludarabine-based conditioning secures engraftment of second hematopoietic stem cell allografts (HSCT) in the treatment of initial graft failureJoseph H Chewning, Hugo Castro-Malaspina, Ann Jakubowski, et al.
Leukemia & Lymphoma|January 12, 2017
Early recovery of T-cell function predicts improved survival after T-cell depleted allogeneic transplantJenna D Goldberg, Junting Zheng, Ravin Ratan, et al.
The Journal of Allergy and Clinical Immunology|December 17, 2009
Improving cellular therapy for primary immune deficiency diseases: recognition, diagnosis, and managementLinda M Griffith, Morton J Cowan, Luigi D Notarangelo, et al.
Pageof 14